Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0128
0.00 (0.00%)
At close: Apr 23, 2026
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $67 thousand as of April 28, 2026. Its market cap has decreased by -97.38% in one year.
Market Cap
67.00K
Enterprise Value
-4.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from 22.32M to 67.00K, a decrease of -99.70%. That is a compound annual growth rate of -62.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 67.00K | 2.40% |
| Dec 31, 2025 | 65.43K | -99.26% |
| Dec 31, 2024 | 8.84M | -64.95% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigyn Therapeutics | 123.33K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| Ocean Biomedical | 92.95K |
| Affymax | 81.94K |
| PaxMedica | 63.14K |
| Amarantus BioScience Holdings | 63.04K |
| Panbela Therapeutics | 53.89K |